D.E. Shaw & Co’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-117,446
| Closed | -$100K | – | 4338 |
|
|
2022
Q2 | $100K | Buy |
117,446
+62,566
| +114% | +$53.3K | ﹤0.01% | 3559 |
|
|
2022
Q1 | $302K | Sell |
54,880
-37,036
| -40% | -$204K | ﹤0.01% | 3443 |
|
|
2021
Q4 | $890K | Sell |
91,916
-11,278
| -11% | -$109K | ﹤0.01% | 2804 |
|
|
2021
Q3 | $1.85M | Sell |
103,194
-26,225
| -20% | -$469K | ﹤0.01% | 2146 |
|
|
2021
Q2 | $3.16M | Sell |
129,419
-39,156
| -23% | -$956K | ﹤0.01% | 1734 |
|
|
2021
Q1 | $4.47M | Buy |
168,575
+7,478
| +5% | +$198K | ﹤0.01% | 1406 |
|
|
2020
Q4 | $1.22M | Buy |
161,097
+123,748
| +331% | +$939K | ﹤0.01% | 1942 |
|
|
2020
Q3 | $187K | Buy |
37,349
+19,958
| +115% | +$99.9K | ﹤0.01% | 2406 |
|
|
2020
Q2 | $104K | Buy |
+17,391
| New | +$104K | ﹤0.01% | 2531 |
|